Alphabet subsidiary DeepMind has cracked a decades-old protein-folding challenge with an artificial intelligence system that could eventually help identify new treatments for diseases, among other nonmedical uses.
"We have been stuck on this one problem – how do proteins fold up? – for nearly 50 years," John Moult, cofounder and chair of the Critical Assessment of protein Structure Prediction (...
